Christopher Cain
Board Member
Jade Biosciences, Inc. (JBIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Cain
Christopher Cain is recorded as Board Member at Jade Biosciences, Inc. (JBIO). Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Christopher Cain was appointed Board of Directors, effective April 28, 2025.
“On April 28, 2025, the Board decreased its size from seven to six members and appointed the following six individuals to the Board: Eric Dobmeier, Christopher Cain, Tom Frohlich, Tomas Kiselak, Lawrence Klein and Erin Lavelle.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jade Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Tom Frohlich CEO, Board Member
- Eric Dobmeier Chairman, Board Member
- Bradford Dahms CFO
- Andrew King CTO
- Elizabeth Balta General Counsel
- Continuing Directors Board Member
- Donald J. Santel Board Member
- Erin Lavelle Board Member
- Habib J. Dable Board Member
- Lawrence Klein Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.